AstraZeneca Pharma India gets DCGI nod to market diabetes drug Industry-The Economic Times — October 17, 2017 comments off The product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca Pharma India said in a statement.